Connect your AI

SION SION Cumulative Cost Basis

Cumulative Cost Basis at other companies

Vertex PharmaceuticalsVRTX

——

AbbVieABBV

——

Denali Therapeutics Inc.DNLI

——

Other financials

Income statement

Operating income-$29.6M-50.6%

Net income-$26.8M-62.5%

EPS (diluted)-$0.60+3.2%

Balance sheet

Cash & equivalents$64.3M-23.2%

Total debt$8.4M-11.8%

Total equity$288.2M-18.1%

Total assets$305.0M-17.5%

Cash flow

Operating cash flow-$21.8M-34.1%

CapEx--100%

Free cash flow-$21.8M-33.4%

Valuation

Market cap$1.86B—

Returns & leverage

Return on equity-26.7%—

Debt / equity0×0.0×

Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is SION's cumulative cost basis?: SION (SION) reported cumulative cost basis of $4.35M in Q1 2026.
How has SION's cumulative cost basis changed year-over-year?: SION's cumulative cost basis increased by 5.4% year-over-year, from $4.12M to $4.35M.